MANHManhattan Associates, Inc.
Is the price fair?
Neither cheap nor expensive: nothing decisive, though modest expectations priced in.
Priced for ~5% a year FCF growth. The price demands less than its three-year revenue growth of 10% a year, expectations look modest.
In its normal range: P/E 58.9 vs a 58.4 median over 41 quarters (+1% vs median).
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What MANH's price assumes
Manhattan Associates, Inc. trades at 58.9× earnings against 33.9× for the median Software - Application name, more expensive than its own group.
Trailing P/E · Software - Application median 33.9 · 1.74× the median: the market pays up for this one
- Price / sales
- 6.70
Price / sales · as of 2026-Q2
- Free cash flow yield
- 5.3%
Free cash flow yield · Software - Application median 6.9%
- Growth the price implies
- +4.9%
Growth the price implies · The price pays for +4.9% free cash flow growth a year for a decade; the business has delivered +28% a year over the last three.
Details›
- Price / bookas of 2026-Q2
- 47.9
- Technology median P/E459 names
- 37.7
- Software - Application median P/E126 names
- 33.9
- Free cash flow, trailing twelve months
- $399M
- Market capitalisation
- $7.57B
- 3-year revenue growth
- +9.9%
- 3-year free cash flow growth
- +28%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $123.38 |
| Its own P/E history, median | $203.23 |
| Its own P/E history, upper quartile | $263.04 |
| 52-week range | $120.88 – $223.36 |
| Today | $205.07 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Software, Application
Ranks #11 of 96 by RyuScore